Abstract
Background
The diverse manifestations of urolithiasis provide very interesting epidemiological data. This has prompted various studies to look into the etiopathogenesis of renal stones, which is believed to be multifactorial, both exogenous and endogenous. VDR Fok1 is a risk factor for renal stone formation and could cause the formation of renal stones through the mechanism of crystal induction and crystallization in the urine. While a few recent studies have shown the role of heavy metals like cadmium and lead in the formation of renal stones, the current knowledge is still insufficient.
Methods
This case-control prospective study was conducted in Guru Teg Bahadur (GTB) Hospital, a tertiary care facility in Delhi with 30 cases and 30 controls. Patients visiting the department of surgery between November 2011 and April 2013 were enrolled in the study. Cases were defined as patients with renal stones diagnosed on the basis of history and radiological investigations. Controls were selected from the patients admitted to the department of surgery for reasons other than renal stones. The study protocol was approved by the Institutional Ethical Committee of the University College of Medical Sciences, GTB Hospital, Delhi. Written informed consent was obtained from all patients. A structured questionnaire was used to collect data. Metal levels were analyzed by an atomic absorption spectrophotometer (Shimadzu Flame AA-680, Shimadzu Corp., Kyoto, Japan) at Delhi University. The vitamin D receptor gene was measured using genomic DNA. Horizontal agarose gel electrophoresis was used for the quantification of the genomic DNA.
Results
There were 30 cases and 30 controls in the study. Stress was more prevalent among cases (63%) compared to controls (36%). Nearly 83% of cases had the ff allele of the Vitamin D receptor gene compared to 46% of controls. The median arsenic and lead levels were higher among cases compared to controls. In the unadjusted model of logistic regression, we found stressed patients had three times higher odds of developing renal stones compared to non-stressed patients (OR (95% CI): 2.98 (1.04-8.52); p=0.04). Similarly, patients with higher blood concentrations of arsenic and lead had higher odds of developing renal stones compared to those with lower concentrations.
Conclusions
There was a definitive role of heavy metals, including lead, cadmium, and arsenic, seen with renal stones. A significant association was seen between the ff allele of VDR polymorphism (Fok1 enzymes) and patients with renal stones. Other parameters, including male and stress factors, seem to have an important role in renal stone formation.
Keywords: fok1 allele, heavy metal, vdr gene, risk factors of renal stones, renal stones, kidney stones
Introduction
Around 1% of emergency admissions are caused by renal colic and complications of renal stones [1]. Kidney stones are common across the world, with a prevalence of about 12% worldwide [2]. Their prevalence in India also reflects worldwide prevalence and stands at approximately 12% [3] and is relatively more common in the northern part of India, where it is 15% [1,3].
The origin of kidney stones is considered multifactorial, being affected by age, gender, family history, diet, comorbidities, environment, genetic inheritance, and other factors [1]. There are high chances of recurrence of kidney stones irrespective of treatment. It is seen that approximately 98% of patients will develop another stone within 25 years of the first episode [1]. The calcium oxalate variety of renal stones is the most common, constituting 60% of all these stones [4].
It has been seen that genetic polymorphism of vitamin D receptor (VDR), Klotho, and chloride voltage-gated channels (CLCN) genes have a role in the formation of kidney stones [4]. VDR is a polymorphic gene having a role in mineral metabolism. It increases the absorption of calcium and excretion of citrate. Studies reveal that multiple allelic variations in VDR, like ApaI, BsmI, TaqI, and Fok1, are associated with nephrolithiasis. VDR Fok1 is a thymine/cytosine polymorphism located at the start (ATG) codon on the 5’ end of VDR, which also showed a role in the formation of renal stones [5].
Another risk factor of renal stone genesis is heavy metals. Heavy metals are a mixed group of elements with metallic properties. Exposure to these heavy metals is mostly via the respiratory or gastrointestinal tracts in the form of cigarette smoke and contaminated food and water. They may cause the formation of renal stones through the mechanism of crystal induction and crystallization in the urine. The toxic manifestations of these metals are primarily due to an imbalance between pro-oxidant and antioxidant homeostasis, which is termed oxidative stress [6]. Cadmium has been a well-known environmental hazard since ancient times [7]. It is used in electroplating, plastics, batteries, mobile phones, and computer circuit boards. In the case of chronic cadmium poisoning, approximately 50% of the accumulated dose is stored in the kidney [7]. B2Micro globulin (b2M) and retinol-binding protein (RBP) in urine are two indicators of early renal toxicity. RBP is said to be the more definitive marker as compared to beta-2 microglobulin, which is also seen in cancer, amyloidosis, and autoimmune diseases like rheumatoid arthritis [7]. As the tubular injury progresses, more generalized tubular dysfunction occurs with wasting and impaired vitamin D metabolism, as well as the reduced conversion of 25-OH vitamin D to 1,25 OH vitamin D and urinary losses of glucose and amino acids, bicarbonate, and phosphate. Cadmium may directly affect bone mineralization, leading to loss of calcium from bone and increased renal excretion. Continued cadmium exposure causes glomerular damage, leading to albuminuria and a progressive decline in glomerular filtration rate (GFR), eventually causing end-stage renal failure [7]. A few recent studies have shown the role of heavy metals like cadmium and lead in the formation of renal stones, although complete knowledge is still deficient [4,7].
In India, few studies are available regarding the risk factors of kidney stones. The present study aims to evaluate various exogenous and endogenous risk factors in patients suffering from renal stones disease.
Materials and methods
Study population
This case-control prospective study was done in Guru Teg Bahadur (GTB) Hospital, a tertiary care facility in Delhi, India with 30 cases and 30 controls. GTB hospital is a 1700-bed government hospital situated in East Delhi and receives 600 patients in the outpatient department and 250 admissions per day [5].
Patients visiting the department of surgery between November 2011 and April 2013 were enrolled in the study. Cases were defined as patients with renal stones diagnosed on the basis of history and radiological investigations (abdominal X-ray or ultrasound abdomen or non-contrast computed tomography of kidney, ureter, and bladder). Controls were selected from the patients admitted to the Department of Surgery for reasons other than renal stones. The study protocol was approved by the Institutional Ethical Committee of the University College of Medical Sciences, GTB Hospital, Delhi. Written informed consent was obtained from all patients.
Data collection and measurements
A structured questionnaire was used to collect data that had questions on socio-demographic characteristics, such as age, gender, marital status, education, occupation, pregnancy status, present history of illness (symptoms suggestive of renal stones), history of past illnesses (stones, congenital anomaly, systemic diseases, drug intake), family history of stones, and personal history of smoking, alcohol, stress, sleeping, dietary habits (vegetarian or non-vegetarian), and drinking water source, etc. Stress was assessed subjectively by asking a patient if he/she felt it or not, and data was collected as yes/no responses.
The questionnaire also captured data on anthropometric measurements (height, weight), clinical parameters (pulse, blood pressure), and biochemical parameters (hemoglobin, serum urea, serum creatinine, blood sugar, serum calcium, lead, cadmium, arsenic, and chromium, urine routine microscopy, and genetic markers (Vitamin D receptor gene with FF, Ff, or ff allele). Patients’ radiological investigations such as abdominal X-ray, abdominal/KUB ultrasound, or non-contrast computed tomography of the kidney, ureter, and bladder were also done in the hospital.
Blood sugar levels at fasting, post-prandial, and random state were obtained. Body mass index was calculated from height and weight using the formula.
Height was measured using the stadiometer to the nearest 0.5 cm after removing shoes/slippers and placing heels together, and weight was measured using a standard digital weighing scale to the nearest 0.1 kg while barefoot and in light clothes. Blood pressure was measured using a digital sphygmomanometer available in the hospital. The blood sample was withdrawn and sent to the laboratory outside the hospital (National Accredited Laboratory affiliated with Delhi University) for the measurements of all the clinical parameters.
Heavy metal was estimated by withdrawing 1.5 ml peripheral blood sample in an EDTA vial, 0.5 ml of blood sample was taken in triplicate in a 100 ml digestion flask fitted with a 30 cm long air condenser, and 5.0 ml distilled HNO3 was added to each sample. The contents were heated at 80°C for 30 minutes. After cooling, 1.5 ml of concentrated perchloric acid (70%) was added, and the sample was heated again at 25°C with occasional shaking till white fumes evolved. The clear solution was cooled and transferred into a 10 ml measuring flask. The volume was made up of 10 ml of deionized water [8]. Thus, the obtained sample was filtered by using a syringe filter of 0.45-micron pore size (RFCL Ltd, New Delhi, India), and the metal levels were analyzed by an atomic absorption spectrophotometer (Shimadzu Flame AA-6800, Shimadzu Corp., Kyoto, Japan) at Delhi University.
The vitamin D receptor gene was measured using genomic DNA. Genomic DNA for genotyping was isolated from whole blood by using a commercially available Himedia Hipura blood genomic DNA isolation kit (HiMedia Laboratories Pvt. Ltd., Mumbai, India) as per the manufacturer’s protocol. The DNA was stored at -22ºC till polymorphic analysis was done. The extracted DNA was quantified by taking the optical density (OD) of the sample at 260 nm wavelength by the Shimadzu UV-2450 spectrophotometer. The purity of DNA was ascertained by taking the ratio of OD at 260 and 280nm. The overall purity of the samples (i.e., OD260/ OD280) ranged between 1.3 and 1.7. Horizontal agarose gel electrophoresis was used for the quantification of the genomic DNA. For analysis of VDR polymorphism, PCR-restriction fragment length polymorphism methods were used [9]. A total of 50 ml reaction mixture consisted of 50 ng of genomic DNA, 10 mM of each primer, 0.2 mM of the dNTPs mixture (Bangalore Genei, Bengaluru, India), 1.5 mM of MgCl2, and 1.5 unit of Taq polymerase with 1× PCR reaction buffer (Bangalore Genei).
Primer Sequence for Genotyping of VDR gene
F5’AGCTGGCCCTGGCACTGACTCTGCTCT-3’ and R5’-ATGGAAACACCTTGCTTCTTCTCCCTC-3’.
The restriction enzyme FokI (Fastdigest, Fermentas, Waltham, MA) was used to distinguish the Fok1 polymorphism. The wild-type allele (FF) produced a double band representing the entire 196, 69 base pair (bp) fragment, and the variant allele (ff) resulted in one fragment of 265 bp, whereas the heterozygous allele (Ff) produced all three bands [9].
Statistical analysis
Descriptive data were presented as frequencies and percentages for the categorical variables and means/medians with standard deviation or interquartile range for numerical variables. The age variable was categorized into three categories (less than 27 years, 27-45 years, and above 45 years). Chi-square was used to compare the difference in the distribution of independent variables (categorical) between cases and controls. We used the Mann-Whitney test to find a statistical difference between cases and controls in the mean levels of serum arsenic, chromium, lead, cadmium, urinary calcium, uric acid, citrate, blood urea, serum calcium, phosphate, creatinine, serum uric acid, and mean body mass index, and diastolic blood pressure.
All the independent variables that showed a statistically significant difference between cases and controls were put in the regression model. Unadjusted and adjusted models of logistic regression were used to explore associations between independent variables and renal stone history. An odds ratio (OR) with a 95% confidence interval (CI) was used to express the strength of the association. Data were analyzed using Statistical Package for Social Sciences (SPSS) for Windows version 27.0 (IBM Corp., Armonk, NY) with a two‑sided p-value of <0.05, which was considered statistically significant.
Results
There were 30 cases and 30 controls in the study. Table 1 shows 60 cases and controls; 42 were males, and 18 were females. There was no statistical difference in the prevalence of history of diseases, smoking, alcohol intake, and drug intake between cases and controls. Stress was more prevalent among cases (63%) compared to controls (36%). In Table 2, nearly 83% of cases had the ff allele of the Vitamin D receptor gene compared to 46% of controls. Table 3 showed no difference in BMI, blood pressure, serum uric acid, serum chromium, serum cadmium, creatinine, serum calcium, and serum phosphate between cases and controls. The median arsenic and lead levels were higher among cases compared to controls. In Table 4, there was no statistically significant difference in the median levels of urinary calcium, urinary citric acid, and urinary uric acid, between cases and controls. Table 5, In the unadjusted model of logistic regression, we found stressed patients had three times higher odds of developing renal stones compared to non-stressed patients (OR (95% CI): 2.98 (1.04-8.52); p=0.04). Similarly, patients with higher blood concentrations of arsenic and lead had higher odds of developing renal stones compared to those with lower concentrations. In the adjusted model, however, most of the associations were insignificant except for stress and the presence of the FF or Ff allele of the Vitamin D receptor gene. Patients with FF or Ff allele had lower odds of developing renal stones than their counterparts (OR (95% CI): 0.15 (0.03-0.80); p=0.02).
Table 1. Distribution of socio-demographic and clinical parameters among cases and controls.
Variables | Cases n=30 | Cases in % | Controls n=30 | Controls in % | P value* | |
Age (years) | Less than 27 years | 14 | 46.7 | 6 | 20.0 | 0.09 |
27-45 years | 9 | 30.0 | 13 | 43.3 | ||
>45 years | 7 | 23.3 | 11 | 36.7 | ||
Gender | Male | 22 | 73.3 | 20 | 66.7 | 0.57 |
Female | 8 | 26.7 | 10 | 33.3 | ||
Residence (city) | Delhi (Urban) | 21 | 70.0 | 19 | 63.3 | 0.50 |
Others | 9 | 30.0 | 11 | 36.7 | ||
Marital status | Married | 20 | 66.7 | 27 | 90.0 | 0.03 |
Unmarried | 10 | 33.3 | 3 | 10.0 | ||
History of drugs intake | Present | 6 | 20.0 | 2 | 6.7 | 0.13 |
Absent | 24 | 80.0 | 28 | 93.3 | ||
History of diseases | Present | 3 | 10.0 | 6 | 20.0 | 0.28 |
Absent | 27 | 90.0 | 24 | 80.0 | ||
History of smoking | Present | 3 | 10.0 | 7 | 23.3 | 0.16 |
Absent | 27 | 90.0 | 23 | 76.7 | ||
History of alcohol intake | Present | 7 | 23.3 | 5 | 16.7 | 0.52 |
Absent | 23 | 76.7 | 25 | 83.3 | ||
Stress | Present | 19 | 63.3 | 11 | 36.7 | 0.04 |
Absent | 11 | 36.7 | 19 | 63.3 | ||
Posture of sleep | Supine | 13 | 43.3 | 21 | 70.0 | 0.02 |
Right | 7 | 23.3 | 7 | 23.3 | ||
Left | 10 | 33.3 | 2 | 6.7 | ||
Diet | Vegetarian | 12 | 40.0 | 18 | 60.0 | 0.12 |
Non-vegetarian | 18 | 60.0 | 12 | 40.0 |
Table 2. Distribution of gene variables across cases and controls.
Variables | Cases n=30 | Cases (%) | Controls n=30 | Controls (%) | P-value | |
Gene | FF and Ff | 5 | 16.7 % | 16 | 53.3% | 0.009* |
ff | 25 | 83.3 % | 14 | 46.7% |
Table 3. Distribution of body mass index, diastolic blood pressure, concentrations of minerals, and serum concentrations of biochemical parameters across cases and controls.
Variables | Cases | Cases median (interquartile range) | Controls | Controls median (interquartile range) | P value |
Body mass index | 23.6 | 20.3-26.0 | 23.9 | 20.7-27.1 | 0.79 |
Diastolic blood pressure | 77.0 | 67.7-86.0 | 78.0 | 71.0-85.5 | 0.59 |
Serum uric acid | 6.0 | 5.2-6.9 | 5.9 | 5.2-6.4 | 0.79 |
Serum arsenic | 0.89 | 0.37-1.24 | 0.31 | 0.14-0.80 | 0.03† |
Serum lead | 2.01 | 0.4-3.3 | 0.39 | 0.1-0.7 | 0.005† |
Serum chromium | 0.46 | 0.2-0.8 | 0.29 | 0.2-0.6 | 0.43 |
Serum cadmium | 0.53 | 0.1-1.2 | 0.19 | 0.1-0.4 | 0.19 |
Blood urea | 28.0 | 21.5-32.5 | 28.0 | 21.0-32.5 | 0.79 |
Serum creatinine | 0.8 | 0.7-1.1 | 0.8 | 0.5-0.9 | 0.79 |
Serum calcium | 8.5 | 7.5-1.1 | 8.8 | 8.1-9.3 | 0.79 |
Serum phosphate | 3.6 | 3.1-4.2 | 3.5 | 3.2-3.9 | 0.79 |
Table 4. Distribution of the concentrations of minerals, and urinary concentrations of biochemical parameters across cases and controls.
Variables | Cases | Cases median (interquartile range) | Controls | Controls median (interquartile range) | P value |
Urinary calcium | 200.5 | 128.2-315.5 | 211.5 | 188.7-290.8 | 0.43 |
Urinary uric acid | 252.0 | 145.5-335.0 | 215.0 | 163.7-287.0 | 0.19 |
Urinary citrate | 3.0 | 2.45-3.9 | 2.7 | 2.3-3.2 | 0.19 |
Table 5. Unadjusted and adjusted models of logistic regression to explore associations between independent variables and cases and controls .
Variables | Unadjusted* odds ratio (95%CI) | Reference | p-value | Adjusted* odds ratio (95% CI) | Reference | p-value | |
Marital status | Married/ unmarried | 0.22 | 0.05-0.91 | 0.03 | 0.31 | 0.05-1.75 | 0.18 |
Stress | Present/ absent | 2.98 | 1.04-8.52 | 0.04 | 5.01 | 1.09-22.90 | 0.03 |
Posture of sleep | Supine/ right/ left | 0.32 | 0.11-0.95 | 0.04 | 0.40 | 0.09-1.74 | 0.22 |
Gene | FF or Ff or ff | 0.17 | 0.05-0.58 | 0.004 | 0.15 | 0.03-0.80 | 0.02 |
Arsenic | 1.82 | 1.11-2.96 | 0.01 | 1.63 | 0.88-3.03 | 0.12 | |
Lead | 1.92 | 1.23-2.99 | 0.004 | 1.62 | 0.96-2.71 | 0.06 |
Discussion
Kidney stones are common and potentially preventable causes of morbidity in the general population. The aim of this study was to study the risk factors in patients with renal stones who visited our institution. A total of 30 cases and 30 age- and gender-matched controls were studied. Patients with radiologically diagnosed renal stones were included in the study.
In the present study, there was a significant difference in the number of males as compared to females with renal stone disease (22 males and eight females, p=0.016). The higher incidence of renal stones in males could be contributed due to the presence of testosterone [1, 6]. A study done in Ballabhgarh Health and Demographic Surveillance System (HDSS) from November 2012 to December 2013 on 433 subjects found that the most common age group affected was 20-40 years; many from this age group are a part of the workforce, which increases the burden on the family and society [10]. Another study published in 2021 also showed that the mean age of renal stone occurrence was 21-40 years [1]. A retrospective study on 435 patients who visited the urology outpatient clinic in Dehradun, India, between 2005 and 2018 showed a high prevalence of renal stones in males, which was almost three times higher than in females. It was also suggested that this prevalence might be due to high levels of testosterone in males [6]. Another study done by Lohiya et al. in northern India, which included 435 renal stones patients, demonstrated a high prevalence of stones in males, which was 1.5 times more than in females [10]. A study done by Semins et al. in approximately 3.4 million insured individuals during a five-year period (2002 to 2006) concluded that the occurrence of renal stones is directly proportional to age, and the disease was twice more common in males as compared to females [11]. Another study done in three cadmium-contaminated villages revealed that there were significant differences between age, gender, alcohol consumption, body mass index, urinary cadmium, and prevalence of diabetes and urinary stones [12].
We were unable to find any association between the risk of urolithiasis with the use of medications and systemic diseases. It has been said that long-term medications, which are possible risk factors for kidney stone formation, include indinavir, thiazide, loop diuretics, thyroid hormones, and antacids. Indinavir stones are seen in 4-12% of treated patients. The possible mechanism of indinavir stone formation is poor solubility and high urinary excretion of this drug. Thiazide causes hypocitraturia whereas loop diuretics cause hypercalcemia [13]. Hyperparathyroidism increases the risk of kidney stone disease by increasing the excretion of calcium, secondary to excessive resorption of bone (known as resorptive hypercalciuria) [14]. Diseases including diabetes mellitus, hypertension, urinary tract infection, gout, inflammatory bowel disease, chronic diarrhea, and cancers like leukemia and lymphomas are associated with the formation of renal stones. In diabetes, the incidence of uric acid stone formation is high due to insulin resistance, a decrease in urinary pH, and obesity which favors uric acid and mixed urate-calcium oxalate stone formation [15]. In hypertension, there is low excretion of citrate and high uric acid excretion along with high BMI, which predisposes to the formation of renal stones [16].
No significance was found between alcohol intake and diet changes with the risk of getting stones. The incidence of renal stone formation increases with a higher intake of alcohol due to an increase in serum uric acid levels [17]. Dietary habits play an important role in the formation of stones. In countries like India, changing lifestyle has increased the tendency for obesity. A fatty diet is thought to create a predisposition to renal stone formation [18].
In the present study, different allele patterns of the VDR (Fok1) gene were found. The incidence of the “ff” allele was significantly higher (p=0.009) in renal stone patients as compared to controls. However, no definitive consensus can be drawn by analyzing previous studies on the higher occurrence of renal stones related to the ff genotype of the VDR gene. Another case-control study on 60 adults aged between 18-90 years showed that VDR and CLDN genes are associated with recurrent urolithiasis. This study also emphasizes the role of methylation of genes in the genesis of renal stones [19]. Another study done in 2015 that included 105 individuals with renal stones showed a significant association of urolithiasis with the FOK1 f allele, which could be directly contributed to the presence of Randall plaques (p=0.047) [20]. In a study published in 2005 by Bid et al. from Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, the association of vitamin D receptor-gene (Fok1) polymorphism with calcium oxalate nephrolithiasis was studied in 138 patients of calcium oxalates stones and 166 healthy patients. The study found a significant association between renal stones and VDR Fok1 polymorphism (p<0.001) [9]. A meta-analysis done by Lin et al. included 17 studies to explore the association between VDR polymorphic sites ApaI, BsmI, TaqI, and Fok1 and urolithiasis risk. This meta-analysis suggested that in the Asian subgroup, there is an increased risk of urolithiasis with the ff + Ff genotype, and VDR polymorphisms could be potential biomarkers for urolithiasis susceptibility [21].
Metabolic factors including lithogenic conditions such as hypercalciuria, hyperuricosuria, hypercalcemia, hyperoxaluria, hyperphosphaturia, hypocitraturia, the excess load of lithogenic substances like vitamin D, and urinary phytate levels have been implicated as risk factors in kidney stone formation. Hypercalciuria causes supersaturation of urine, which leads to the development of renal stones [22]. Hyperuricosuria is an important metabolic risk factor in the formation of uric acid stones. The etiologic mechanisms for uric acid stone formation are diverse and include congenital, acquired, and idiopathic causes. Major factors for the development of uric acid stones are low urine volume, acidic urine pH, and hyperuricosuria. However, abnormally acidic urine is the principal determinant in uric acid crystallization [22]. Hypocitraturia, with a urinary citrate level of less than 320 mg/day is another important and correctable metabolic cause of renal stones. It is seen in 10% of patients having calcium stones [14]. Our study didn’t find a strong correlation between metabolic disease and the incidence of renal stones.
Exposure to heavy metals from cigarette smoke and food from contaminated soil and water. The kidney is the main target organ for these heavy metals. Surprisingly, not too many studies have been done on this topic. A recent study published in 2021 done in China on non-occupational exposure found 3.16 times the odds of renal stones with a high level of lead in blood (>100μg/L) in males; however, the odd ratio became 3.43 in the presence of high cadmium in urine and high-level leads in blood. In females, there is a significant correlation between nephrolithiasis and a combination of both high blood lead and urinary cadmium (OR 2.58) [23]. A study was done on 6,748 individuals with exposure to environmental cadmium. The study population was screened for urinary cadmium and calcium levels and the presence of urolithiasis. A strong association was found between urinary cadmium levels and stone prevalence after adjusting other co-variables. The stone prevalence increased 1.093-fold for every 1 µg increase in urinary cadmium when adjusted for urinary creatinine. It was also found that urinary calcium levels increased parallel to increasing urinary cadmium, and this was possibly the mechanism by which cadmium resulted in urinary stone formation [12].
Another study published in 2007 by Bazin et al. suggested the role of heavy metals in stone formation through crystal induction, and the highest proportion of the heavy metals in calcium stones was observed for Zn (mean ± SD= 525 ± 768ppm), followed by Sr (239 ± 300 ppm), Fe (35 ± 43 ppm) and Pb (19 ± 27 ppm) while the other metals accounted for less than 10 ppm on average [6]. A study done on factory workers suggested that an increase in cadmium dose was associated with multiple renal tubular functional abnormalities, including a decrease in resorption of beta-2 microglobulin, retinol-binding protein (RBP), calcium, and phosphate and a rise in mean systolic and diastolic blood pressures. The study also suggested that serum creatinine concentration also increased with an increase in cadmium dosage due to impaired glomerular function. Serum cadmium concentration was significantly higher in the exposed workers than in the unexposed (7.9 v 1.2 µg/l, p< 0.0001). The average blood lead concentration was higher in cadmium workers than in the unexposed (11.9 v 8.3 pg/l, p = 0.0013) [24]. A prospective study by Järup and Elinder on cadmium-exposed battery workers showed similar results [25].
In our study, we estimated the serum levels of heavy metals by atomic absorption spectrometry. The serum levels in the patients (cadmium 0.73±0.65; lead 10.29±4.54; arsenic 0.923±0.71ng/ml) were significantly higher than the corresponding levels in the controls (cadmium 0.324±0.27; lead 0.574±0.51; arsenic 0.371±0.29 ng/ml). However, no significant difference was seen in serum levels of chromium in cases and controls.
Even in 2022, we don’t have much information regarding the correlation between psychological stress in the formation of renal stones. A study done by Miyaoka et al. on 200 patients with nephrolithiasis concluded that high stress is related to the stones (p = 0.012) and recurrence of excretion of urinary stones(p=0.022). The author used the PSS-10 score for stress level analysis, and females and unemployment were the confounding factors [26]. Another case-controlled study done at the Center of New Jersey in Newark with 200 individuals matched with age, sex, and race found that three important factors, such as low total annual family income, mortgage issues, and emotional life events that last for more than a week were associated with a higher risk of formation of renal stones (p <0.05) [27].
Strengths and limitations of the study
This study opens a newer perspective to studying the relationship between the FOK1 VDR gene and heavy metals with renal stones. However, this study was conducted in a selected hospital in Delhi, and the sample size was also small; therefore, its generalizability is limited. There was no stress scale used in this study and individual perceptions of stress might be different for different individuals.
Conclusions
In this case-control study, we studied various risk factors in the formation of renal stones in 30 patients with renal stones (with 30 controls) who visited GTB Hospital, New Delhi. There was a definitive role of heavy metals, including lead, cadmium, and arsenic, seen with renal stones (more with lead). A significant association was seen between the ff allele of VDR polymorphism (Fok1 enzymes) and patients with renal stones. Other parameters, including male gender and stress factors, seem to play an important role in renal stone formation. We conclude that people visiting the outpatient department or admitted to wards should be counseled on these risk factors to prevent the incidence or recurrence of renal stones.
Acknowledgments
I gladly take this opportunity to express my deep sense of gratitude to my mentor, Professor Dr. Sanjay Gupta. It has been a great privilege for me to work under him. His ever-ready attitude to help, valuable suggestions in the moment of despair, and relentless dedication to research, have always been a constant and valuable support and guidance that made this task not only easier for me but also possible in the stipulated time. I would remain indebted to him for his constant encouragement and excellent guidance. I would like to express a deep debt of gratitude to Professor Dr. Tushar S. Mishra, for his valuable input throughout the study. It has been a great privilege for me to work under him. He was always supportive and eager to help. His valuable guidance helped me to make this task possible. I immensely thank Dr. B.D. Banerjee, for his complete support that boosted my morale and encouraged me to move on. His valuable thoughts helped me in understanding this task. I would like to express my gratitude to Professor Dr. Arun Sharma and Mr. Rajeev for helping, guiding, and encouraging me during the course of my study. I am thankful to my entire family, especially my mum Mrs. Usha Singh and my husband Dr. Kumar Vinayak Singh for their love, blessings, and emotional support throughout this study. I thank all my friends and well-wishers who have offered me help in their own ways but left unacknowledged. I acknowledge and thank all the staff of the department of General Surgery and Department of Biochemistry, University College of Medical Sciences & Associated Hospitals, for their kind support throughout the study. Finally, I am grateful to all the research participants, without whom this study would not have been possible.
The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.
The authors have declared that no competing interests exist.
Human Ethics
Consent was obtained or waived by all participants in this study. University of Medical Sciences, Delhi, India issued approval n/a. I completed this dissertation during my Master of Surgery (M.S. General Surgery).
Animal Ethics
Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.
References
- 1.A 13 year hospital based study on the trend of urinary stone disease in Uttarakhand, India. Kakkar M, Kakkar R. Nepal J Epidemiol. 2021;11:949–958. doi: 10.3126/nje.v11i1.35896. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Nojaba L, Guzman N. StatPearls. Treasure Island, FL: StatPearls Publishing; 2022. Nephrolithiasis. [PubMed] [Google Scholar]
- 3.The demographic diversity of food intake and prevalence of kidney stone diseases in the Indian continent. Guha M, Banerjee H, Mitra P, Das M. Foods. 2019;8:37. doi: 10.3390/foods8010037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Confounding risk factors and preventative measures driving nephrolithiasis global makeup. Shin S, Srivastava A, Alli NA, Bandyopadhyay BC. World J Nephrol. 2018;7:129–142. doi: 10.5527/wjn.v7.i7.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Government of NCT, Delhi. Guru Teg Bahadur Hospital, Delhi. Available from: http://health.delhigovt.nic.in/wps/wcm/connect/doit_gtbh/GTBH/Home/General+Information. Accessed 22 July. 2022. http://health.delhigovt.nic.in/wps/wcm/connect/doit_gtbh/GTBH/Home/General+Information http://health.delhigovt.nic.in/wps/wcm/connect/doit_gtbh/GTBH/Home/General+Information
- 6.Heavy elements in urinary stones. Bazin D, Chevallier P, Matzen G, Jungers P, Daudon M. Urol Res. 2007;35:179–184. doi: 10.1007/s00240-007-0099-z. [DOI] [PubMed] [Google Scholar]
- 7.Heavy metal poisoning: the effects of cadmium on the kidney. Johri N, Jacquillet G, Unwin R. Biometals. 2010;23:783–792. doi: 10.1007/s10534-010-9328-y. [DOI] [PubMed] [Google Scholar]
- 8.NIOSH Manual of Analytical Methods (NMAM). Chromium and compounds, as Cr: METHOD 7024. [ Feb; 2023 ];https://www.cdc.gov/niosh/docs/2003-154/pdfs/7024.pdf NIOSH Manual of Analytical Methods (NMAM) 1994 4:1–4. [Google Scholar]
- 9.Association of vitamin D receptor-gene (FokI) polymorphism with calcium oxalate nephrolithiasis. Bid HK, Kumar A, Kapoor R, Mittal RD. J Endourol. 2005;19:111–115. doi: 10.1089/end.2005.19.111. [DOI] [PubMed] [Google Scholar]
- 10.Population-based estimate of urinary stones from Ballabgarh, northern India. Lohiya A, Kant S, Kapil A, Gupta SK, Misra P, Rai SK. Natl Med J India. 2017;30:198–200. doi: 10.4103/0970-258X.218671. [DOI] [PubMed] [Google Scholar]
- 11.The association of increasing body mass index and kidney stone disease. Semins MJ, Shore AD, Makary MA, Magnuson T, Johns R, Matlaga BR. J Urol. 2010;183:571–575. doi: 10.1016/j.juro.2009.09.085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.An association between urinary cadmium and urinary stone disease in persons living in cadmium-contaminated villages in northwestern Thailand: a population study. Swaddiwudhipong W, Mahasakpan P, Limpatanachote P, Krintratun S. Environ Res. 2011;111:579–583. doi: 10.1016/j.envres.2011.01.007. [DOI] [PubMed] [Google Scholar]
- 13.Pearle MS, Lotan Y. Campbell-Walsh Urology, 10th ed. Philadelphia, PA: Elsevier Saunders; 2012. Urinary lithiasis: etiology, epidemiology, and pathogenesis; pp. 1257–1286. [Google Scholar]
- 14.Analysis of primary hyperparathyroidism screening among US veterans with kidney stones. Ganesan C, Weia B, Thomas IC, et al. http://10.1001/jamasurg.2020.2423. JAMA Surg. 2020;155:861–868. doi: 10.1001/jamasurg.2020.2423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Presence of gallstones or kidney stones and risk of type 2 diabetes. Weikert C, Weikert S, Schulze MB, et al. https://doi.org/10.1093/aje/kwp411. Am J Epidemiol. 2010;171:447–454. doi: 10.1093/aje/kwp411. [DOI] [PubMed] [Google Scholar]
- 16.Increased acid excretion in kidney stone formers with essential hypertension. Losito A, Nunzi EG, Covarelli C, Nunzi E, Ferrara G. https://doi.org/10.1093/ndt/gfn468. Nephrol Dial Transplant. 2009;24:137–141. doi: 10.1093/ndt/gfn468. [DOI] [PubMed] [Google Scholar]
- 17.A complementary approach to urolithiasis prevention. Anderson RA. https://doi.org/10.1007/s00345-002-0294-z. World J Urol. 2002;20:294–301. doi: 10.1007/s00345-002-0294-z. [DOI] [PubMed] [Google Scholar]
- 18.Obesity, weight gain, and the risk of kidney stones. Taylor EN, Stampfer MJ, Curhan GC. JAMA. 2005;293:455–462. doi: 10.1001/jama.293.4.455. [DOI] [PubMed] [Google Scholar]
- 19.The correlation between promoter hypermethylation of VDR, CLDN, and CasR genes and recurrent stone formation. Khatami F, Gorji A, Khoshchehreh M, et al. BMC Med Genomics. 2022;15:109. doi: 10.1186/s12920-022-01265-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Demographics and characterization of 10,282 Randall plaque-related kidney stones: a new epidemic? Letavernier E, Vandermeersch S, Traxer O, et al. Medicine (Baltimore) 2015;94:0. doi: 10.1097/MD.0000000000000566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Vitamin D receptor genetic polymorphisms and the risk of urolithiasis: a meta-analysis. Lin Y, Mao Q, Zheng X, Chen H, Yang K, Xie L. Urol Int. 2011;86:249–255. doi: 10.1159/000323949. [DOI] [PubMed] [Google Scholar]
- 22.Should patients with single renal stone occurrence undergo diagnostic evaluation? Pak CY. J Urol. 1982;127:855–858. doi: 10.1016/s0022-5347(17)54106-3. [DOI] [PubMed] [Google Scholar]
- 23.Association of lead and cadmium exposure with kidney stone incidence: A study on the non-occupational population in Nandan of China. Huang JL, Mo ZY, Li ZY, et al. J Trace Elem Med Biol. 2021;68:126852. doi: 10.1016/j.jtemb.2021.126852. [DOI] [PubMed] [Google Scholar]
- 24.Nephropathy in cadmium workers: assessment of risk from airborne occupational exposure to cadmium. Thun MJ, Osorio AM, Schober S, Hannon WH, Lewis B, Halperin W. Br J Ind Med. 1989;46:689–697. doi: 10.1136/oem.46.10.689. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Incidence of renal stones among cadmium exposed battery workers. Järup L, Elinder CG. Br J Ind Med. 1993;50:598–602. doi: 10.1136/oem.50.7.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Correlation between stress and kidney stone disease. Miyaoka R, Ortiz-Alvarado O, Kriedberg C, Alanee S, Chotikawanich E, Monga M. J Endourol. 2012;26:551–555. doi: 10.1089/end.2010.0536. [DOI] [PubMed] [Google Scholar]
- 27.Stressful life events and risk of symptomatic kidney stones. Najem GR, Seebode JJ, Samady AJ, Feuerman M, Friedman L. Int J Epidemiol. 1997;26:1017–1023. doi: 10.1093/ije/26.5.1017. [DOI] [PubMed] [Google Scholar]